Induction Healthcare Group PLC Block Listing Six Monthly Return (0093O)

TIDMINHC

RNS Number : 0093O

Induction Healthcare Group PLC

27 January 2023

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

Block Listing Six Monthly Return

Induction Healthcare (AIM: INHC), a leading digital health platform driving transformation of healthcare systems worldwide, makes the following six-monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies:

 
 Name of applicant:                               Induction Healthcare Group PLC 
 
                                                   LEI: 213800RY96GCZQW5TP19 
 Name of scheme:                                  The Induction Healthcare NTA Share 
                                                   Option Plan 
                                                 ------------------------------------------- 
 Period of return:                                 From:    27/07/2022    To:     26/01/2023 
                                                 --------  ------------  ------  ----------- 
 Number and class of securities                   3,500,000 ordinary shares on 26 July 
  originally admitted and the date                 2021 
  of admission 
                                                 ------------------------------------------- 
 Balance of unallotted securities 
  under scheme(s) from initial 
  application:                                    3,103,433 
                                                 ------------------------------------------- 
 Plus: The amount by which the                    Nil 
  block scheme(s) has been increased 
  since the date of the last return 
  (if any increase has been applied 
  for): 
                                                 ------------------------------------------- 
 Less: Number of securities issued/allotted       Nil 
  under scheme(s) during the period: 
                                                 ------------------------------------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at end 
  of period:                                      3,103,433 
                                                 ------------------------------------------- 
 Contact:                                         Louise Torr, Company Secretary 
                                                   [e-mail] 
                                                 ------------------------------------------- 
 
 
 

ENQUIRIES

 
 Induction                                 Via Walbrook PR Ltd: [e-mail] 
  Christopher Samler, Executive Chair 
  Paul Tambeau, Chief Operating Officer 
 
 Singer Capital Markets (Nominated 
  Adviser and Broker)                                                [phone] 
 Philip Davies 
 
 Walbrook PR Ltd                                                [e-mail] 
 Paul McManus / Alice Woodings                     Mob: [phone] 
                                                                                 804 654 
 

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions through a single integrated platform that transforms care delivery. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems.

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BLRNKABKQBKDKDB

(END) Dow Jones Newswires

January 27, 2023 02:00 ET (07:00 GMT)